Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, MasterCard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Earn
Launch
CandyDrop
tag
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Diğerleri
TradFi
Rewards
ISRG

Intuitive Surgical Inc Price

ISRG
$467,98
+$8,97(+%1,95)

*Data last updated: 2026-04-08 13:08 (UTC+8)

As of 2026-04-08 13:08, Intuitive Surgical Inc (ISRG) is priced at $467,98, with a total market cap of $160,85B, a P/E ratio of 70,77, and a dividend yield of %0,00. Today, the stock price fluctuated between $465,11 and $469,20. The current price is %0,61 above the day's low and %0,26 below the day's high, with a trading volume of 1,78M. Over the past 52 weeks, ISRG has traded between $447,77 to $469,20, and the current price is -%0,26 away from the 52-week high.

ISRG Key Stats

Yesterday's Close$452,58
Market Cap$160,85B
Volume1,78M
P/E Ratio70,77
Dividend Yield (TTM)%0,00
Diluted EPS (TTM)8,04
Net Income (FY)$2,85B
Revenue (FY)$10,06B
Earnings Date2026-04-28
EPS Estimate2,08
Revenue Estimate$2,62B
Shares Outstanding355,42M
Beta (1Y)1.679

About ISRG

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
SectorHealthcare
IndustryMedical - Instruments & Supplies
CEODavid J. Rosa
HeadquartersSunnyvale,CA,US
Official Websitehttps://www.intuitive.com
Employees (FY)17,02K
Average Revenue (1Y)$591,31K
Net Income per Employee$167,79K

Intuitive Surgical Inc (ISRG) FAQ

What's the stock price of Intuitive Surgical Inc (ISRG) today?

x
Intuitive Surgical Inc (ISRG) is currently trading at $467,98, with a 24h change of +%1,95. The 52-week trading range is $447,77–$469,20.

What are the 52-week high and low prices for Intuitive Surgical Inc (ISRG)?

x

What is the price-to-earnings (P/E) ratio of Intuitive Surgical Inc (ISRG)? What does it indicate?

x

What is the market cap of Intuitive Surgical Inc (ISRG)?

x

What is the most recent quarterly earnings per share (EPS) for Intuitive Surgical Inc (ISRG)?

x

Should you buy or sell Intuitive Surgical Inc (ISRG) now?

x

What factors can affect the stock price of Intuitive Surgical Inc (ISRG)?

x

How to buy Intuitive Surgical Inc (ISRG) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

ISRG
CFD
Trade

Hot Posts About Intuitive Surgical Inc (ISRG)

NodeGuardian

NodeGuardian

6 hours ago
This article argues that PODD, a peer to Intuitive Surgical (ISRG) in the Health Care Equipment industry, offers better value and growth. PODD has a lower valuation (P/OpInc) but higher revenue and operating income growth compared to ISRG, suggesting a potential buying opportunity for PODD stock over ISRG. The analysis includes a comparison of key financial metrics, both currently and a year prior, to demonstrate PODD's consistent outperformance in growth.
1
0
0
0
SelfRugger

SelfRugger

6 hours ago
Intuitive Surgical AI Push And Global Expansion Tested By Rich Valuation ======================================================================== Simply Wall St Tue, February 17, 2026 at 6:10 AM GMT+9 3 min read In this article: ISRG Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. * Intuitive Surgical is integrating artificial intelligence into its robotic surgery systems across its platforms. * The company reports strong global procedure volumes and continued growth in minimally invasive surgery adoption. * Recent investments are focused on expanding direct operations and deepening its presence in key European markets. For investors watching NasdaqGS:ISRG, the story is not just about surgical robots; it is about how those systems are being upgraded with AI and scaled worldwide. The shares last closed at $485.84, with a 3 year return of 103.4% and a 5 year return of 96.6%, which gives useful context around how the market has historically valued the company’s progress in robotic assisted care. What stands out in the latest updates is the mix of product development, heavier research spending, and a bigger operational footprint in Europe. For you as an investor, these moves frame Intuitive Surgical as a company working to deepen the clinical relevance of its systems and widen access to its platforms, factors that can shape how its role in the medtech space evolves over time. Stay updated on the most important news stories for Intuitive Surgical by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Intuitive Surgical. NasdaqGS:ISRG Earnings & Revenue Growth as at Feb 2026 3 things going right for Intuitive Surgical that this headline doesn't cover. ### Investor Checklist ### Quick Assessment * **✅ Price vs Analyst Target**: The current price of US$485.84 sits about 21% below the US$611.82 analyst target, with a published range from US$378 to US$750. * **❌ Simply Wall St Valuation**: Shares are described as trading 28.4% above estimated fair value, so the price is rich relative to that model. * **❌ Recent Momentum**: The 30 day return of about 9.2% decline flags short term weakness despite the positive news flow. There is only one way to know the right time to buy, sell or hold Intuitive Surgical. Head to Simply Wall St's company report for the latest analysis of Intuitive Surgical's Fair Value. ### Key Considerations * 📊 AI integration, strong global procedure volumes and investment in direct operations suggest the business is leaning into its strengths in minimally invasive care. * 📊 With a P/E of about 60.4 versus a Medical Equipment peer average near 30.4, you may want to track how earnings, procedure growth and AI adoption progress against that premium. * ⚠️ The combination of a 28.4% premium to estimated fair value and a recent 9.2% decline in the share price raises the risk of further volatility if expectations are not met. Story Continues ### Dig Deeper For the full picture including more risks and rewards, check out the complete Intuitive Surgical analysis. Alternatively, you can check out the community page for Intuitive Surgical to see how other investors believe this latest news will impact the company's narrative. _ This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ _Companies discussed in this article include ISRG._ **Have feedback on this article? Concerned about the content? Get in touch with us directly.**_ Alternatively, email [email protected]_ Terms and Privacy Policy Privacy Dashboard More Info
1
0
0
0
MeaninglessApe

MeaninglessApe

9 hours ago
Spin-offs are a great tool for businesses, helping them rationalize ongoing business, focus on growth, and unlock shareholder value. The key question is whether a separation changes how investors might evaluate the original company, the new company, or both as standalone stories. Get **HON** alerts: Sign Up FedEx on Track to Deliver Value-Building Savings  ------------------------------------------------- FedEx’s NYSE: FDX spin suggests both the **original and new companies are buyable**. The spin-off separates the freight business from the core package delivery business, enabling both companies to trade at freer valuations. The critical takeaway for potential investors in the freight company is that it may trade at a 50% or higher premium to the original. The hurdle for the freight business is 2026 headwinds, including tepid demand, margin pressure, and expansion costs. ![](https://img-cdn.gateio.im/social/moments-e6e5eb580a-92365433d0-8b7abd-badf29) Takeaways for investors in the original FDX include improvements in operational quality, cash flow, and the reliability of capital returns. FedEx’s capital return is significant, comprising dividends, dividend growth, and aggressive share buybacks. Buybacks reduced the count by more than 2.5% year-to-date as of the end of fiscal Q3 2026. Analysts are lifting price targets ahead of the split, indicating a Moderate Buy with potential to hit new highs by mid-year.  KBR Split Enhances Focus, Unlocks Growth Avenues ------------------------------------------------ KBR’s NYSE: KBR split and spin-off, scheduled for completion in the back half of 2026, aims to separate its Sustainable Technology Solutions business from its government business. The new company will comprise the Mission Technology Solutions group, which includes defense, security, and space applications. Among the reasons for this spin is the unlocking of value; the spinco may experience a 100% to 200% price gain based on the original’s 9X multiple. Defense specialists such as Lockheed Martin NYSE: LMT, Northrop Grumman NYSE: NOC, and RTX NYSE: RTX trade at well over 20 times earnings.  ![](https://img-cdn.gateio.im/social/moments-227da90873-1bd7a60712-8b7abd-badf29) While the spinco will focus on** defense contracts and execution** of its massive backlog, the ongoing business will focus on higher margin sustainable energy technologies. The leaner company will benefit from speedier decision-making and financial flexibility, enabling it to continue investing in its future. Analyst revisions are mixed in 2026, but the trend is stable, leaving the rating at Hold and the consensus price target forecasting about a 50% upside.  Medtronic to Spin-Off High-Growth Diabetes Unit ----------------------------------------------- Medtronic NYSE: MDT plans to spin off its high-growth diabetes unit later this year, a move that, at face value, seems counterintuitive. However, the diabetic unit is a consumer-oriented business while the core is business-to-hospital, presenting challenges for the combined company. The result will be a pure-play diabetic equipment and supply company, able to **compete effectively** in its high-growth market, and with the potential for takeover. ![](https://img-cdn.gateio.im/social/moments-738183e0b9-43a93e288a-8b7abd-badf29) The remaining company will focus on high-growth, higher-margin businesses such as cardiovascular and robotic surgery. Robotic surgery is the future of medicine, with leaders such as Intuitive Surgical NASDAQ: ISRG sustaining double-digit growth rates and steadily improving operational quality. Twenty-six analysts rate this stock as a Moderate Buy, coverage is increasing, the sentiment is firm, and the consensus price target forecasts more than 25% upside as of late March.  Keurig Dr Pepper: Grows to Split, Unleashes Global Powerhouses -------------------------------------------------------------- Keurig Dr Pepper NASDAQ: KDP has struggled for years as strengths and weaknesses in the soda business offset strengths and weaknesses in the coffee business. Now, the company plans to make another coffee acquisition, then spin the coffee bundle into a pure-play for investors. The combined business will experience supply chain efficiencies and unlock growth opportunities, specifically in the high-margin coffee pod industry.  ![](https://img-cdn.gateio.im/social/moments-681dea740c-40182abff2-8b7abd-badf29) The ongoing business will be a soda-and-beverage pureplay, **unencumbered **by coffee-specific issues, with an enhanced financial profile. It will be able to focus on its higher-margin businesses and growth, including acquisitions, and is expected to be completed in April. Analysts are bullish on this stock, rating it a Moderate Buy and raising price targets ahead of the spin-off. The consensus price target reported by MarketBeat forecasts close to 35% upside, while the high-end of price targets adds double digits.  Honeywell Splits to Enhance Focus With 2 Pureplay Businesses  ------------------------------------------------------------- Honeywell NASDAQ: HON aims to split its aerospace business into a more focused pure-play unit. It will service defense and commercial contracts, execute on a record backlog, and improve cash flow while the original business focuses on industrial automation. Industrial automation is the linchpin of the Industrial Revolution 4.0 and the nexus of Internet of Things (IoT), robotics, and AI. The spin allows it a more **flexible financial position**, enabling strategic acquisitions to sustain growth long-term.  ![](https://img-cdn.gateio.im/social/moments-938a259740-1e622c15cf-8b7abd-badf29) Analyst trends suggest the group is most bullish on this stock. MarketBeat’s data reflects swelling coverage, firming sentiment pegged at Moderate Buy, and an uptrend in the price targets. Consensus forecasts call for a 10% upside in late March, and the trends point to the high end and are likely to remain strong through year-end.  Should You Invest $1,000 in Honeywell International Right Now? -------------------------------------------------------------- Before you consider Honeywell International, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Honeywell International wasn't on the list. While Honeywell International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ![](https://img-cdn.gateio.im/social/moments-248e7ccf6c-cc2835e184-8b7abd-badf29) 7 Stocks That Will Be Magnificent in 2026 Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets. Get This Free Report
0
0
0
0